The Crowd Has Wisely Soured on Cassava Sciences Stock

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

As perceptions rise that its flagship drug candidate won't make it to market, steer clear of SAVA stock.

The post The Crowd Has Wisely Soured on Cassava Sciences Stock appeared first on InvestorPlace.

• Stock Prodigy Who Found NIO at $2… Says Buy THIS
• It doesn’t matter if you have $500 in savings or $5 million. Do this now.
• Get in Now on Tiny $3 ‘Forever Battery’ Stock
• Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”